Gerard Silvestri to Biomarkers
This is a "connection" page, showing publications Gerard Silvestri has written about Biomarkers.
Connection Strength
0.636
-
Assessment of Plasma Proteomics Biomarker's Ability to Distinguish Benign From Malignant Lung Nodules: Results of the PANOPTIC (Pulmonary Nodule Plasma Proteomic Classifier) Trial. Chest. 2018 09; 154(3):491-500.
Score: 0.409
-
Incorporating Baseline Lung Function in Lung Cancer Screening: Does a "Lung Health Check" Help Predict Outcomes? Chest. 2021 04; 159(4):1664-1669.
Score: 0.123
-
Surrogate Markers and the Association of Low-Dose CT Lung Cancer Screening With Mortality. JAMA Oncol. 2018 07 01; 4(7):1006-1008.
Score: 0.105